Open access
Oct 2026
Hematopoietic Cell Transplantation Outcomes in the Era of Post-Transplant Cyclophosphamide: Comprehensive Donor Analysis.
It is suggested that PTCy narrows outcome differences across donor types, shifting donor selection from rigid hierarchies and supporting timely HCT using the best available donor.
Y. Aljawai, Masumi Ueda Oshima, Varuna Astha et al.
· Blood Advances · 0 citations